Brief: Biohaven - Federal Court Confirms Ra Capital And Avilar Therapeutics "Misappropriated" Yale Trade Secret
25/08/2026 21:44
BRIEF-Biohaven - Federal Court Confirms Ra Capital And Avilar Therapeutics "Misappropriated" Yale Trade Secret Aug 25 (Reuters) - Biohaven Ltd. BHVN.N:
BIOHAVEN - FEDERAL COURT CONFIRMS RA CAPITAL AND AVILAR THERAPEUTICS "MISAPPROPRIATED" YALE TRADE SECRET
BIOHAVEN - U.S. DISTRICT COURT AWARDS $4 MILLION TO BIOHAVEN AND YALE IN TRADE SECRET CASE
Source text: ID:nPn2t1sYza
Further company coverage: BHVN.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biohaven
See all newsBrief: Biohaven - FDA Accepts Biohaven NDA Resubmission For Vyglxia (Troriluzole) In SCA
Biohaven jumps as FDA takes second look at brain disorder drug
Brief: Biohaven Enters Strategic Licensing Agreement With Ono Pharma
Ono Pharma Announces An Exclusive License Agreement With Biohaven To Develop And Commercialize Igg Degraders In Japan, South Korea, Taiwan, And Asean
U.S. STOCKS ON THE MOVE-Macy's, American Eagle, Designer Brands